Compounds > ciglitazone

ciglitazone and l-165041

ciglitazone has been researched along with l-165041 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buckley, KA; Chan, BY; Dillon, JP; Fraser, WD; Gallagher, JA; Gartland, A; Wilson, PJ1
Lerch, R; Montessuit, C; Papageorgiou, I; Pellieux, C1
Lerch, R; Montessuit, C; Papageorgiou, I1
Aleshin, S; Grabeklis, S; Hanck, T; Reiser, G; Sergeeva, M1
Chopra, B; Georgopoulos, NT; Hinley, J; Nicholl, A; Oleksiewicz, MB; Southgate, J1

Other Studies

5 other study(ies) available for ciglitazone and l-165041

ArticleYear
PPAR agonists modulate human osteoclast formation and activity in vitro.
    Bone, 2007, Volume: 40, Issue:1

    Topics: Acetates; Apoptosis; Bezafibrate; Bone Resorption; Butyrates; Cells, Cultured; Fenofibrate; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Macrophage Colony-Stimulating Factor; Osteoclasts; Peroxisome Proliferator-Activated Receptors; Phenols; Phenoxyacetates; Phenylurea Compounds; RANK Ligand; RNA, Messenger; Thiazolidinediones; Transcription, Genetic

2007
Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pflugers Archiv : European journal of physiology, 2007, Volume: 455, Issue:3

    Topics: Acyl-CoA Dehydrogenase; Animals; Atrial Natriuretic Factor; Cardiomegaly; Carnitine O-Palmitoyltransferase; CD36 Antigens; Cells, Cultured; Male; Myocytes, Cardiac; Oleic Acid; Palmitates; Phenoxyacetates; PPAR alpha; PPAR delta; PPAR gamma; PPAR-beta; Pyrimidines; Rats; RNA, Messenger; Thiazolidinediones

2007
Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
    Endocrinology, 2008, Volume: 149, Issue:3

    Topics: Alitretinoin; AMP-Activated Protein Kinase Kinases; Animals; Cells, Cultured; Cytoskeleton; Glucose; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Microtubules; Myocytes, Cardiac; Phenoxyacetates; PPAR gamma; Protein Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Signal Transduction; Thiazolidinediones; Tretinoin

2008
Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Molecular pharmacology, 2009, Volume: 76, Issue:2

    Topics: Animals; Animals, Newborn; Astrocytes; Biomarkers; Brain; Butyrates; Cells, Cultured; Cyclooxygenase 2; Drug Combinations; Gene Expression Regulation, Enzymologic; Glial Fibrillary Acidic Protein; Lipopolysaccharides; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Phenylurea Compounds; PPAR alpha; PPAR delta; PPAR gamma; PPAR-beta; Protein Isoforms; Rats; Rosiglitazone; Thiazolidinediones; Time Factors

2009
Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
    Cell proliferation, 2009, Volume: 42, Issue:5

    Topics: Apoptosis; Calcium; Calcium Channels; Caspase 3; Caspase 9; Cell Division; Cells, Cultured; Chromans; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fenofibrate; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Membrane Potential, Mitochondrial; Oxazines; p38 Mitogen-Activated Protein Kinases; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Phenylpropionates; Rosiglitazone; Thiazolidinediones; Troglitazone; Urothelium

2009